Cite
HARVARD Citation
William, S. et al. (n.d.). P031 Ozanimod in Patients with Moderate-to-Severe Ulcerative Colitis: Long-Term Safety and Efficacy from the Phase 2 TOUCHSTONE Study 4-Year Open-Label Extension. American journal of gastroenterology. p. S8. [Online].